Urinary heme oxygenase-1 as a possible marker for early diagnosis of diabetic nephropathy and retinopathy

Background Early detection of DN helps in primary prevention of this complication. Microalbuminuria has been proven as a useful biomarker for diagnosis of DN. Heme oxygenase-1 is an essential enzyme in heme catabolism induced by oxidative stress. It plays a pivotal role in maintaining renal function and protecting renal structure under conditions of oxidative stress such as proteinuria. Urinary heme oxygenase-1 may appear early before the development of microalbuminuria, so it can be used as a marker for early detection of DN. Patients and methods A total of 80 type 2 diabetic patients with and without DN were compared with 20 healthy control subjects matched in age and sex. They were divided into two groups: group I included 40 normoalbuminuric patients with albumin-to-creatinine ratio (ACR) less than 30 mg/g, and group II included 40 microalbuminuric patients with ACR 30–300 mg/g. For all studied groups, full history and clinical examination were done. Glycosylated hemoglobin, urinary ACR (mg/g), estimated glomerular filtration rate, urinary creatinine, and urine hemoxygnase-1 (UHO-1) and UHO-1/creat ratio by enzyme-linked immunosorbent assay were performed. Results Microalbuminuric patients had significantly higher levels of UHO-1 (5.02) compared with normoalbuminuric patients (3.01) and controls (0.3), with P less than 0.001, and normoalbuminuric patients had significantly higher levels of UHO-1 compared with control subjects, with P less than 0.001. UHO-1/Cr levels were significantly positively correlated with urinary ACR but significantly negatively correlated with glomerular filtration rate and systolic and diastolic blood pressures (P<0.001). By linear regression, there was a highly significant correlation between HO1and estimated glomerular filtration rate. Conclusion HO-1 was increased in patients with proteinuria and increased before the onset of microalbuminuria, indicating UHO-1 is more sensitive than albumin for the detection of early DN with no relation to diabetic retinopathy.

• Publication year

  2023

• Venue

  Journal of The Egyptian Society of Nephrology and Transplantation

• Publication date

  2023-07-01

• Fields of study

  Not labeled

• Identifiers
  DOI 10.4103/jesnt.jesnt_29_22
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• A review on heme oxygenase-1 induction: is it a necessary evil

  2018cited by this paper
• Recent advances in managing and understanding diabetic nephropathy

  2016cited by this paper
• The effects of medical management on the progression of diabetic retinopathy in persons with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Eye Study.

  2014cited by this paper
• Correlation of Microalbuminuria with Estimated GFR (eGFR) by Cockcroft–Gault and MDRD Formula in Type 2 Diabetics and Hypertensives

  2014cited by this paper
• Oxidative Stress/Angiotensinogen/Renin-Angiotensin System Axis in Patients with Diabetic Nephropathy

  2013cited by this paper
• Heme oxygenase-1 as a target for TGF-β in kidney disease.

  2012cited by this paper
• Heme oxygenase-1: a provenance for cytoprotective pathways in the kidney and other tissues.

  2006cited by this paper
• Disturbances in 24-hour blood pressure regulation in diabetic subjects

  2003cited by this paper
• Selective protection of renal tubular epithelial cells by heme oxygenase (HO)-1 during stress-induced injury.

  2003cited by this paper

• No citing papers are available for this paper.